This Article Order Full text via Infotrieve Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Joris, I. Articles by Lewis, R. A. Search for Related Content PubMed PubMed Citation Articles by Joris, I. Articles by Lewis, R. A.

American Journal of Pathology, Vol 126, 19-24, Copyright © 1987 by American Society for Investigative Pathology

REGULAR ARTICLES

The mechanism of vascular leakage induced by leukotriene E4. Endothelial contraction

I Joris, G Majno, EJ Corey and RA Lewis

This study identifies the microvascular target of leukotriene E4 (LTE4) by vascular labeling with carbon black and establishes the mechanism of its action at the cellular level by electron microscopy. LTE4 and its tripeptide precursor, leukotriene C4 (LTC4) were injected subcutaneously in guinea pigs. With LTE4, venular labeling was intense at 1000 and 100 ng and slight at 10 ng, with extinction at 1 ng. LTC4 induced a ring of labeled venules around a blank central area, suggestive of vasospasm. The nonpeptidyl leukotriene LTB4 induced no labeling. Histamine (1000 ng) induced an area of vascular labeling about equal to that by 1000 ng LTE4, but the labeling of individual venules was more intense. By electron microscopy, LTE4 was found to induce gaps in the endothelium of the venules; the endothelial cells adjacent to the gaps bulged into the lumen and showed wrinkled nuclei, consistent with cellular contraction. This ultrastructural evidence suggests that LTE4 increases vascular permeability by contraction of endothelial cells selectively, in the postcapillary venules, as was previously demonstrated for other inflammatory mediators, including histamine, serotonin, and bradykinin.

This article has been cited by other articles:

				B. Troyanovsky, D. F. Alvarez, J. A. King, and K. L. Schaphorst Thrombin enhances the barrier function of rat microvascular endothelium in a PAR-1-dependent manner Am J Physiol Lung Cell Mol Physiol, February 1, 2008; 294(2): L266 - L275. [Abstract] [Full Text] [PDF]

				G. Su, M. Hodnett, N. Wu, A. Atakilit, C. Kosinski, M. Godzich, X. Z. Huang, J. K. Kim, J. A. Frank, M. A. Matthay, et al. Integrin {alpha}vbeta5 Regulates Lung Vascular Permeability and Pulmonary Endothelial Barrier Function Am. J. Respir. Cell Mol. Biol., March 1, 2007; 36(3): 377 - 386. [Abstract] [Full Text] [PDF]

				K. Tokita, Y. Uchida, and T. Yamamoto Roles of leukocytosis and cysteinyl leukotriene in polymorphonuclear leukocyte-dependent plasma extravasation J. Leukoc. Biol., December 1, 2006; 80(6): 1308 - 1319. [Abstract] [Full Text] [PDF]

				A. Ek, L. Palmberg, and K. Larsson The effect of fluticasone on the airway inflammatory response to organic dust Eur. Respir. J., October 1, 2004; 24(4): 587 - 593. [Abstract] [Full Text] [PDF]

				D. E. Sloniewsky, K. M. Ridge, Y. Adir, F. P. Fries, A. Briva, J. I. Sznajder, and P. H. S. Sporn Leukotriene D4 Activates Alveolar Epithelial Na,K-ATPase and Increases Alveolar Fluid Clearance Am. J. Respir. Crit. Care Med., February 1, 2004; 169(3): 407 - 412. [Abstract] [Full Text] [PDF]

				A. C. Yopp, G. J. Randolph, and J. S. Bromberg Leukotrienes, Sphingolipids, and Leukocyte Trafficking J. Immunol., July 1, 2003; 171(1): 5 - 10. [Full Text] [PDF]

				C. Brink, S.-E. Dahlen, J. Drazen, J. F. Evans, D. W. P. Hay, S. Nicosia, C. N. Serhan, T. Shimizu, and T. Yokomizo International Union of Pharmacology XXXVII. Nomenclature for Leukotriene and Lipoxin Receptors Pharmacol. Rev., March 1, 2003; 55(1): 195 - 227. [Abstract] [Full Text] [PDF]

				T. Ezaki, P. Baluk, G. Thurston, A. La Barbara, C. Woo, and D. M. McDonald Time Course of Endothelial Cell Proliferation and Microvascular Remodeling in Chronic Inflammation Am. J. Pathol., June 1, 2001; 158(6): 2043 - 2055. [Abstract] [Full Text] [PDF]

				A. M. Dvorak and D. Feng The Vesiculo-Vacuolar Organelle (VVO): A New Endothelial Cell Permeability Organelle J. Histochem. Cytochem., April 1, 2001; 49(4): 419 - 432. [Abstract] [Full Text]

				P. HEDQVIST, N. GAUTAM, and L. LINDBOM Interactions between Leukotrienes and Other Inflammatory Mediators/Modulators in the Microvasculature Am. J. Respir. Crit. Care Med., February 1, 2000; 161(2): S117 - 119. [Full Text] [PDF]

				R. S. Byrum, J. L. Goulet, J. N. Snouwaert, R. J. Griffiths, and B. H. Koller Determination of the Contribution of Cysteinyl Leukotrienes and Leukotriene B4 in Acute Inflammatory Responses Using 5-Lipoxygenase- and Leukotriene A4 Hydrolase-Deficient Mice J. Immunol., December 15, 1999; 163(12): 6810 - 6819. [Abstract] [Full Text] [PDF]

				P. Gosling Prevention of post-traumatic clinical capillary leak syndrome Trauma, April 1, 1999; 1(2): 91 - 103. [Abstract] [PDF]

				G. T. Simonian, H. Dardik, D. Hallac, R. Mazziotta, I. Ibrahim, and R. Stahl Hemodynamic and Histopathologic Effects of Hydroxyethyl Starch and Superoxide Dismutase Following Splanchnic Arterial Occlusion in a Murine Model Vascular and Endovascular Surgery, September 1, 1997; 31(5): 645 - 656. [Abstract] [PDF]

				K. E. Pedersen, B. S. Bochner, and B. J. Undem Cysteinyl Leukotrienes Induce P-Selectin Expression in Human Endothelial Cells via a Non-CysLT1 Receptor-Mediated Mechanism J. Pharmacol. Exp. Ther., May 1, 1997; 281(2): 655 - 662. [Abstract] [Full Text]

				S. Homer-Vanniasinkam and M. J. Gough The Role of Leukotrienes in Controlling Postischemic Skeletal Muscle Function Vascular and Endovascular Surgery, October 1, 1993; 27(8): 585 - 589. [Abstract] [PDF]